COMPARISON OF TYROSINE-KINASE INHIBITORS AS FIRST-LINE TREATMENT FOR CHRONIC MYELOID LEUKEMIA: RESULTS OF A NETWORK META-ANALYSIS INCLUDING 6314 PATIENTS

MLA

Skoetz, N., et al. Comparison of Tyrosine-Kinase Inhibitors as First-Line Treatment for Chronic Myeloid Leukemia: Results of a Network Meta-Analysis Including 6314 Patients. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1247372504&authtype=sso&custid=ns315887.

APA

Skoetz, N., Rancea, M., Trelle, S., Nueesch, E., Engert, A., & Kreuzer, K. A. (2015). Comparison of Tyrosine-Kinase Inhibitors as First-Line Treatment for Chronic Myeloid Leukemia: Results of a Network Meta-Analysis Including 6314 Patients.

Chicago

Skoetz, N., M. Rancea, S. Trelle, E. Nueesch, A. Engert, and K. A. Kreuzer. 2015. “Comparison of Tyrosine-Kinase Inhibitors as First-Line Treatment for Chronic Myeloid Leukemia: Results of a Network Meta-Analysis Including 6314 Patients.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1247372504&authtype=sso&custid=ns315887.